After hours
You're reading the free version. Trader adds the live tape and alerts. Start tracking
Sale
Calculated transaction value
$94.32K

Rothblatt Martine A Chairperson & CEO

Transaction date Jun 16, 2026
Public filing date Jun 17, 2026
Filing lag Filed 1 day later

UTHR daily price context

Close on/before transaction
$548.27 Jun 16, 2026
First close after public filing
$536.59 Jun 18, 2026
30-day return after filing
-0.17% Through Jul 17, 2026

Source details

Reported owner
Not disclosed
Source asset code
Security
Security
Common Stock
Quantity / price
173 shares @ $545.18
SEC ownership
Direct
Transaction code
S
Form
4
Filing identifier
0001106578-26-000080
Filing cohort

Transactions in this filing

Showing 12 of 12
Trades
12
Issuers
1
Estimated value
$6.61M
Buys / sales
0 / 10
Transactions reported in the same official filing
Issuer Transaction Traded Value
United Therapeutics Corp UTHR Exercise Jun 16, 2026 $1.39M
United Therapeutics Corp UTHR Current Sale Jun 16, 2026 $94.32K
United Therapeutics Corp UTHR Sale Jun 16, 2026 $286.67K
United Therapeutics Corp UTHR Sale Jun 16, 2026 $296.54K
United Therapeutics Corp UTHR Sale Jun 16, 2026 $1.11M
United Therapeutics Corp UTHR Sale Jun 16, 2026 $611.18K
United Therapeutics Corp UTHR Sale Jun 16, 2026 $1.12M
United Therapeutics Corp UTHR Sale Jun 16, 2026 $990.66K
United Therapeutics Corp UTHR Sale Jun 16, 2026 $381.63K
United Therapeutics Corp UTHR Sale Jun 16, 2026 $213.5K
United Therapeutics Corp UTHR Sale Jun 16, 2026 $116.47K
United Therapeutics Corp UTHR Exercise Jun 16, 2026 $0